NDC11 81806020073
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 81806-0200-73 | 81806-0200 |
| 81806-200-73 | 81806-200 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Deflazacort Oral Suspension | DEFLAZACORT | Doppel Farmaceutici S.r.l. | 40a833a4-e029-a99e-e063-6394a90afd50 | 2026-07-29 | Warnings, Adverse reactions | 81806-200-73 81806-200 81806020073 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.